Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake

Thyroid

Volumn 10, Issue 12, 2000, Pages 1043-1050

  Benvenga, Salvatore ^a,b   Lakshmanan, Mark ^a,b   Trimarchi, Francesco ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CARNITINE; HORMONE ANTAGONIST; IODINE 125; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL LINE; CELL NUCLEUS MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEPATOMA CELL; HORMONE ACTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; ISOTOPE LABELING; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANIMALS; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; CARNITINE; CELL LINE; CELL NUCLEUS; FIBROBLASTS; HUMANS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MICE; NEUROBLASTOMA; THYROID HORMONES; THYROXINE; TRIIODOTHYRONINE; TUMOR CELLS, CULTURED;

EID: 0034500998     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.1043     Document Type: Article

References (42)

1. The role of carnitine in cell metabolism
2. Carnitine transport
3. Carnitine-Metabolism and functions
4. Carnitine and derivatives in tissues
5. Turnover of carnitine by rat tissues
6. Carnitine uptake and diploid cells aging in culture
7. Mitochondrial metabolism of pyruvate in bovine spermatozoa
8. Carnitine in the male reproductive tract and its relation to the metabolism of the epididymis and spermatozoa
9. Hydroxylation of γ-butyrobetaine to carnitine in humans and monkey tissues
10. Tissue distribution of carnitine biosynthetic enzymes in man
11. Active transport of butyrobetaine and carnitine into isolated liver cells
12. The uptake of carnitine by slices of rat cerebral cortex
13. In vivo studies of intestinal carnitine absorption in rats
14. Protective effect of L-carnitine in experimental intoxication with diphtheria toxin
15. Carnitine deficiency: Primary and secondary syndromes
16. The effect of L-carnitine on the AZT-induced destruction of human myotubes: Part II Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction
17. Wirkungen von karnitin bei uberfunction der schildrusse
18. Aminotransferasen unter Thyroxin und Karnitin
19. The antagonistic effect of carnitine in hyperthyroidism: Preliminary report
20. Urinary excretion of carnitine in patients with hyperthyroidsim and hypothyroidism: Augmentation by thyroid hormone
21. Effect of thyroxine treatment on carnitine levels in mice
22. The twenty-four urinary excretion of carnitine and creatinine in normal and hypothyroid children
23. Carnitine metabolism in thyroid hormone-treated rats and mice
24. Enhancement of thyroxine entry into low density lipoprotein (LDL)-receptor-competent fibroblasts by LDL: An additional mode of entry of thyroxine into cells
25. Tri-iodothyronine transport into differentiated and undifferentiated mouse neuroblastoma cells NB 41A3
26. Differential effect of a new thyromimetic on tri-iodothyronine transport into myoblasts and hepatoma and neuroblastoma cells
27. The transport of thyroxine into mouse neuroblastoma cells NB 41A3
28. Phloretin inhibits cellular uptake and nuclear receptor binding of tri-iodothyronine in human HepG2 hepatocarcinoma cells
29. Nuclear thyroid hormone receptors in cultured human fibroblasts: Improved method of isolation, partial characterization and interaction with chromatin
30. LIGAND: A versatile computerized approach for characterization of ligand-binding systems
31. Thyroid hormone efflux from monolayer cultures of human fibroblasts and hepatocytes: Effect of lipoproteins and other thyroxine transport proteins
32. Multiple thyroid hormone binding sites on rat liver nuclear envelopes
33. Specific binding proteins of thyroxine and tri-iodothyronine in liver soluble proteins
34. Metabolism of L-thyroxine (L-T4) and L-tri-iodothyronine (T3) by human fibroblasts in tissue culture: Evidence for cellular binding proteins and conversion of T4 to T3
35. Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein
36. Membrane iodothyronine transporter: Part I. Review of physiology
37. Thyroid hormone export regulates cellular hormone content and response
38. 5, 5′-diphenylhydantoin decreases specific 3, 5, 3′-tri-iodothyronine (T3) binding by rat hepatic T3 receptors
39. Uptake of 3, 5, 3′-tri-iodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal antinflammatory drugs
40. −125Itri-iodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines
41. Receptor-mediated uptake of 3, 3′, 5′-triodo-L-thyronine by cultured fibroblasts
42. Carnitine (C) as a peripheral antagonist of thyroid hormones (TH): A clinical trial